Section Arrow
Quote
CURX.NASDAQ
- Curanex Pharmaceuticals Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/03/11 06:59 EDT
Pre Market
Last
 0.41
-0.0099 (-2.36%)
Bid
0.41
Ask
0.4499
High 0.41 
Low 0.41 
Volume 171 
Regular Hours (Closed)
Last
 0.41
+0.0201 (+5.16%)
Day High 
0.4353 
Prev. Close
0.3899 
1-M High
0.6666 
Volume 
485.41K 
Bid
0.41
Ask
0.4499
Day Low
0.3701 
Open
0.3725 
1-M Low
0.2713 
Market Cap 
10.77M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.4 
20-SMA 0.35 
50-SMA 0.35 
52-W High 9.1796 
52-W Low 0.262 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.05/--
Enterprise Value
10.77M
Balance Sheet
Book Value Per Share
0.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LGVNLongeveron0.891+0.3611+68.14%-- 
Pre Market 0.821 -0.07 -7.86%
BRTXBioRestorative Therapies0.2848+0.05015+21.37%-- 
Pre Market 0.2559 -0.0255 -9.06%
QNCXQuince Therapeutics0.104-0.0025-2.35%-- 
Pre Market 0.1033 +0.0022 +2.18%
ACXPAcurx Pharmaceuticals2.9+0.945+48.34%-- 
Pre Market 3.43 +0.53 +18.28%
PLYXPolaryx Therapeutics Inc5.97+2.44+69.12%-- 
Pre Market 5.56 -0.41 -6.87%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.